Polpharma API is a European CDMO offering small-molecule, oligonucleotide, and payload-linker for ADC development and manufacturing
About the Plant
We are one of the leading European CDMO companies with over seven decades of experience in supporting patients’ health with high-quality APIs.We offer comprehensive capabilities that span a broad spectrum of cutting-edge technologies and end-to-end solutions—from process development to large-scale commercial production. Our expertise includes:- High Potency APIs (HP APIs)- Payloads & Linkers- Oligonucleotides- Cryogenic processesOur cutting-edge facilities for R&D, pilot production, manufacturing, and quality control, combined with the extensive expertise in developing and manufacturing highly complex APIs, enable us to offer a diverse range of services across the entire value chain. Supported by an engaged, highly skilled, and accountable team of nearly 500 experts, we partner with clients throughout the entire product life cycle, from early-stage clinical candidates to commercial launches, ensuring seamless collaboration and consistent results at every stage.- We are proud of our 75 years of experience in supporting patients’ health with high-quality APIs,- Generics and CDMO business from development to commercial,- European location of R&D and 2 manufacturing plants- Fast decision-making, Customer orientation, Top execution- Project management excellence, Global Market presence, Broad Type of Chemistries